In addition to mediating inflammatory responses, ANXA1 is involved in the development of multiple tumors, metastasis and drug resistance and may be used as a potential biomarker for tumor diagnosis, treatment, and prognosis [25, 26]. Here, ANXA1 is linked to neoplasm.